International Journal of Breast Cancer / 2018 / Article / Fig 5

Research Article

CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy

Figure 5

Event-free survival. Figure 5 shows curves comparing event-free survival in patients with CDK9 positive versus CDK9 negative tumors. There is no statistically significant or observable difference in the two survival curves.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.